This page collects WhisperX intelligence signals tagged #ophthalmology. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Kodiak Sciences Inc. (KOD) stock surged after the biotech company announced its lead candidate, KSI-301, met its primary endpoint in a pivotal Phase 3 trial for diabetic retinopathy. The positive topline results from the GLEAM study mark a critical inflection point, demonstrating the antibody biopolymer conjugate's pot...
Biogen is making a massive $5.6 billion bet on immunology, announcing a deal to acquire Apellis Pharmaceuticals at a price more than double the biotech's recent share value. The upfront cash offer of $41 per share represents a dramatic premium, signaling Biogen's aggressive push to secure commercial-stage assets and re...
Laser surgical systems maker Lensar is projecting a bold financial target for 2026, forecasting gross margins between 46% and 49%. This forward-looking guidance signals the company's strategic pivot to reignite growth as an independent entity, following the termination of its acquisition deal with industry giant Alcon....
A new smart contact lens has demonstrated the dual capability to continuously monitor intraocular pressure and deliver glaucoma medication on-demand in early-stage testing. This development directly targets the silent, insidious nature of glaucoma—the world's second-leading cause of blindness—where an estimated half of...